Viewing Study NCT01679860


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-27 @ 11:24 PM
Study NCT ID: NCT01679860
Status: COMPLETED
Last Update Posted: 2012-09-06
First Post: 2012-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module